
aTyr Pharma, Inc.
aTyr Pharma, Inc.(ATYR)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
atyr · 股价预测 · 10 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Hold
10 位分析师
共识
评级分布
12 个月目标价
High
$17.00
Consensus
$5.13
+1060.4% upside
Low
$1.00
Median: $1.25 · Last Close: $0.44
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.42 | ↓ 5.00% |
1-day model range: $0.41–$0.43. Peak: $0.43 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ATYR · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-20 | Freedom Broker | Upgrade ↑ | Hold→Buy |
| 2025-11-07 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-09-16 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2025-09-16 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2025-09-15 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2025-09-15 | LUCID CAPITAL MARKETS | Downgrade ↓ | Buy→Neutral |
| 2025-09-15 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-09-15 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2025-09-15 | Jones Trading | Downgrade ↓ | Buy→Hold |
| 2025-08-22 | Jefferies | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on aTyr Pharma, Inc. (ATYR) stock. Of the recent 27 rating actions, 1 were upgrades and 7 were downgrades. 10 analysts currently cover ATYR.
分析师推荐趋势
ATYR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$4M
↓ 90.8% YoY
Revenue Next Year
$9M
↑ 127.9% YoY
EPS This Year
$-0.57
EPS Next Year
$-0.62
↑ 8.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ATYR EPS of $-0.57 for the current fiscal year, based on estimates from 4 analysts. The ATYR revenue forecast is $4M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ATYR 股价预测由两类独立数据源支撑:来自 10 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ATYR 的共识目标价为 $5.13(+1060.4% 上行空间),分析师共识为 Hold。
ATYR 的短期预测(明日)为 $0.42(-5.00%)。
aTyr Pharma, Inc. 在 NASDAQ 上市,代码 ATYR。ATYR 在 2027 年的整体展望偏中性/分化,在覆盖分析师中约 30% 对应 Hold 共识。
常见问题
ATYR 预测 · 8 个问题根据 10 位华尔街分析师,ATYR 的 12 个月平均目标价为 $5.13,最高 $17.00、最低 $1.00。若有图表,中位目标价可在上方查看。相对当前价 $0.44,隐含约 +1060.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.